Do Pharma Sites Block AI Crawlers? 1 of 8 Do

One pharmaceutical site out of the 8 we found with a parseable robots.txt file blocks at least one AI crawler — a block rate of 12.5%. That single exception is rxlist.com, a drug reference database. Every major global drug manufacturer and pharmacy benefit platform we checked — pfizer.com, novartis.com, merck.com, gsk.com, abbvie.com, lilly.com, and goodrx.com — published a robots.txt that places no restrictions on any AI crawling agent. One site in the set, astrazeneca.com, returned no robots.txt at all.

This report is a per-category slice of the US Tech Automations Research Closing Web snapshot: a point-in-time census of 572 sites across 56 categories, sealed June 14, 2026 (snapshot sha 4e7c4a4a3c720f06). Every figure here is a verbatim count from that sealed file — nothing is estimated, modeled, or extrapolated. A sealed snapshot means the robots.txt content was collected, hashed, and locked; these numbers describe what the files said on that specific day, not a trend.

Key Takeaways

1 of 8 Pharma sites with a parseable robots.txt blocks at least one AI crawler.

The Pharma block rate is 12.5% — well below the corpus-wide rate of 33.4%.

rxlist.com is the sole blocker in the Pharma category.

Across all 479 sites in the corpus, CCBot is blocked by 124 sites — the most of any single crawler.

102 of 479 sites with a parseable robots.txt publish an llms.txt file, a 21.3% adoption rate.

"1 of 8 Pharma sites with a parseable robots.txt blocks at least one AI crawler — a 12.5% block rate against a corpus average of 33.4%."

Who Gates the Crawlers Here — and Who Does Not

The defining characteristic of the Pharma category in this snapshot is not restriction — it is openness. The single blocker, rxlist.com, is a consumer drug-information reference database rather than a drug manufacturer. Reference databases that aggregate drug monographs from multiple sources have a documented sensitivity around their proprietary data organization; rxlist.com appears to have acted on that concern in its robots.txt policy.

By contrast, the global pharmaceutical manufacturers in the set — pfizer.com, novartis.com, merck.com, gsk.com, abbvie.com, and lilly.com — all return parseable robots.txt files that permit every crawling agent we checked. That pattern is notable. These are organizations with extensive intellectual property, regulatory filing content, and clinical trial data. Yet their public-facing web properties welcome AI crawlers without restriction.

The most plausible explanation is channel strategy. A large drug manufacturer's public website is primarily a communication and investor-relations surface. It does not host the compound databases, assay data, or proprietary clinical outputs that would be worth protecting from scraping. The valuable proprietary data sits behind authenticated portals or in regulatory filings — not in publicly crawlable pages.

goodrx.com, a pharmacy benefit comparison platform, also allows all crawlers. GoodRx operates on the premise that broader information access drives consumer traffic; restricting AI crawlers would run counter to that model.

astrazeneca.com returned no robots.txt file in this snapshot. The absence of a file is not a block — crawlers treat a missing robots.txt as permission to proceed — but it does mean we cannot confirm an explicit policy. That site is in the noRobotsSites group, not the blockers.

"Every major global pharmaceutical manufacturer in this snapshot — pfizer.com, novartis.com, merck.com, gsk.com, abbvie.com, and lilly.com — permits all AI crawlers in its robots.txt."

Where Pharma Sits Among Its Neighbors in the Corpus

Pharma lands at 12.5% — well below the corpus-wide average. Across all 479 sites in the snapshot, 160 block at least one AI crawler, a rate of 33.4%. Pharma sits considerably below that line without being at the absolute floor.

The focused window below shows Pharma alongside its nearest neighbors in the block-rate ranking, where the shift from single-digit to low-double-digit rates is concentrated:

For contrast, here are the highest- and lowest-blocking categories across the corpus:

Pharma sits in a band with Government, Crypto, Books, and Education — categories where one isolated site breaks an otherwise permissive pattern. It is not the lowest-blocking category, but it is clearly on the permissive half of the corpus. The clean-zero categories at the floor — including the subjects of Do Logistics Sites Block AI Crawlers? and Do Manufacturing Sites Block AI Crawlers? — are predominantly B2B-industrial sectors where Pharma's pattern is a slight step up from zero.

Which Bots Are Blocked Most — Across All 479 Sites

To understand the broader context of AI crawler blocking, the bot-level leaderboard across all 479 sites in the corpus shows which agents face the most resistance regardless of category:

CCBot, the web crawler operated by Common Crawl, is blocked by 124 of the 479 sites with a parseable robots.txt — more than any other agent. ClaudeBot comes second at 108 sites. GPTBot and Bytespider follow closely. For the Pharma category, rxlist.com's robots.txt is the lone contributor to any of these counts.

The operator-level view tells a similar story. Common Crawl faces disallow rules from 124 sites corpus-wide, Anthropic from 117, and OpenAI from 101. The gap between the top-blocked operator (Common Crawl, 124) and the least-blocked in our tracked set (Mistral, 24) spans the same logic: operators associated with large-scale training data collection face stronger headwinds than those newer to the crawling landscape.

For the Pharma category specifically, rxlist.com's robots.txt contributes to some of these operator counts, but the seven allower sites are not contributing any restriction signals to any bot.

How the Snapshot Was Sealed

We collected publicly accessible robots.txt files from each of the 572 sites in our panel on June 14, 2026. The process:

1. Collect. Each site's robots.txt was fetched via HTTP. Sites without a reachable robots.txt file are classified as noRobots — they are not treated as blockers, because the absence of a file does not restrict any crawler.

2. Parse. Each parseable robots.txt was scanned for Disallow directives targeting any of 9 tracked AI crawling user-agents: CCBot, ClaudeBot, GPTBot, Bytespider, Meta-ExternalAgent, Applebot-Extended, Google-Extended, PerplexityBot, and Amazonbot. A site is classified as a blocker if at least one such directive exists.

3. Seal. All parsed outputs were written to a content-addressed snapshot file and sha256-hashed. The resulting sha is 4e7c4a4a3c720f06. Nothing is estimated, modeled, or extrapolated. Every number in this report is a verbatim count from that sealed file.

4. Aggregate. Sites are grouped by category. The Pharma category contains 9 sites; 8 returned a parseable robots.txt; 1 of those 8 carries at least one AI-crawler disallow directive.

The robots.txt standard is an honor system — any crawler that ignores the file can still reach the content. The data here describes policy declarations, not enforcement outcomes. A site that blocks a crawler in its robots.txt has signaled intent; whether every crawler respects that signal is outside the scope of this snapshot.

Frequently Asked Questions

Q: Why would a drug reference site block crawlers when drug manufacturers do not?

A: rxlist.com hosts a structured database of drug monographs — curated, formatted, and organized for specific consumer queries. That data organization has competitive value; a crawler that ingests the full corpus could replicate the query surface without any agreement. A drug manufacturer's website, by contrast, is primarily a communication layer over publicly disclosed information. The incentive to block differs between the two business models.

Q: Does a missing robots.txt mean a site is blocking crawlers?

A: No. A missing robots.txt — like astrazeneca.com in this snapshot — means the site has not published a policy file. Web crawlers treat the absence of a robots.txt as implicit permission to proceed. The noRobotsSites in this report are sites that simply did not return a parseable robots.txt file; they are not classified as blockers.

Q: Does blocking a crawler in robots.txt actually stop it?

A: Not necessarily. The robots.txt standard is an honor system with no technical enforcement mechanism. A crawler that ignores the Disallow directive can still fetch the pages. In practice, reputable AI operators — including OpenAI, Anthropic, Google, and Meta — have stated commitments to respect robots.txt. Smaller or less reputable crawlers may not. A robots.txt block signals intent and creates a contractual foundation for legal action, but it is not a firewall.

Q: How does Pharma compare to sibling health-adjacent categories in this snapshot?

A: Healthcare (a distinct category covering clinics, hospital systems, and health media) blocks crawlers at 66.7%, the same rate as Entertainment and Music. Pharma at 12.5% is dramatically lower than Healthcare, which reflects the difference between public-facing hospital and consumer-health platforms (which gate AI access more aggressively) and pharmaceutical manufacturer sites (which use their public web presence primarily for communications).

Q: Will the Pharma block rate change over time?

A: This is a point-in-time snapshot sealed June 14, 2026. We do not have a prior Pharma observation to compare against, and nothing in this data permits a trend claim. The more useful question is: what would trigger a change? If AI-generated drug information begins to create regulatory or liability risk for manufacturers, we would expect to see robots.txt policies tighten. For now, the signal is permissive.

Q: Can I use this data to decide whether to crawl a specific pharma site?

A: You can use it as a starting-point reference for the sites named in this report. However, robots.txt files change. A policy that was open on June 14, 2026 may have changed since. Any production crawling decision should re-fetch the current robots.txt directly rather than relying on a point-in-time sealed snapshot. This data is most useful for policy tracking over time — detecting when a previously open site adds a restriction.

Put AI-Access Data to Work

For anyone working inside or alongside the pharmaceutical sector, the 12.5% block rate is an input, not a conclusion. Here are three concrete use cases built on the sealed figures.

Pharma regulatory-data product manager — A product lead at a drug information platform tracks whether competitor reference databases (including rxlist.com) adjust their robots.txt policies as AI-generated drug information matures. The trigger is any new Disallow directive targeting GPTBot or ClaudeBot on a previously open site. The cadence is weekly re-crawl; if rxlist.com expands its block list or if a currently open manufacturer site adds restrictions, the product team reassess how to position their own data access layer. A single manufacturer adding restrictions would shift the corpus and signal a possible industry pivot point.

AI training-data procurement lead — An organization building pharmaceutical knowledge bases monitors this category on a recurring basis to confirm which properties remain openly accessible. The 7 allower sites in this snapshot — pfizer.com, novartis.com, merck.com, gsk.com, abbvie.com, lilly.com, goodrx.com — are confirmed open as of June 14, 2026. The workflow: weekly re-fetch, alert immediately if any allower site gains a Disallow directive for any of the 9 tracked bots. Drift in a previously permissive category is often the earliest signal that an industry is reconsidering its AI-access posture.

Content intelligence analyst — Teams monitoring pharmaceutical communications for regulatory, investor-relations, or competitive-intelligence purposes rely on AI crawlers to surface new content from manufacturer sites. Knowing that the major manufacturer sites are currently open simplifies pipeline planning. US Tech Automations automates this monitoring with scheduled robots.txt crawls, change-diff alerts, and an AI-access policy dashboard so your team knows the moment any tracked domain shifts from permissive to restrictive. See how the workflow runs at /platform/agentic-workflows.

For the broader category picture, see how logistics and manufacturing sites compare in Do Logistics Sites Block AI Crawlers? and Do Manufacturing Sites Block AI Crawlers?.

The HR and accounting categories are also worth comparing — see Do HR Sites Block AI Crawlers?.

Source: US Tech Automations Research — Closing Web edition; figures are verbatim counts from public robots.txt files sealed June 14, 2026 (snapshot sha 4e7c4a4a3c720f06).